# PreciThera

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precithera

- Industry: Pharmaceuticals
- Headquarters: Montreal, Canada
- Website: www.precithera.com
- Total disclosed funding: $29M
- Latest round: Series A (Jul 27, 2017)
- Investors on record: 4

## About

Founded in 2016 and based in Montreal, Canada, PreciThera, Inc. operates as a precision medicine company, developing biological agents for the treatment of orphan diseases.

## Funding rounds

- Series A, Jul 27, 2017, $29M — Sanderling Ventures, Fonds de Solidarité des Travailleurs du Québec, Emerillon Capital, Arix Bioscience
- Seed, May 10, 2017 — Sanderling Ventures, Emerillon Capital

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Seed, Series A
- Emerillon Capital — Seed, Series A
- Fonds de Solidarité des Travailleurs du Québec — Series A
- Arix Bioscience (https://capitalatlas.ai/funds/arix-bioscience) — Series A